Streptokinase is produced from
**Core Concept**
Streptokinase is a thrombolytic agent used to dissolve blood clots. It is produced by certain strains of streptococci, specifically Group C and Group G beta-hemolytic streptococci. These bacteria produce streptokinase as a virulence factor to facilitate their spread through the bloodstream.
**Why the Correct Answer is Right**
Streptokinase works by activating the plasminogen-plasmin system, which breaks down fibrin clots. It does this by binding to plasminogen and converting it into plasmin, an enzyme that degrades fibrin. The activation of the plasminogen-plasmin system leads to the dissolution of blood clots, making streptokinase an effective treatment for conditions such as pulmonary embolism and acute ischemic stroke.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because streptokinase is not produced by Staphylococcus aureus. S. aureus produces different virulence factors such as coagulase and staphylokinase.
**Option B:** Incorrect because urokinase is a different thrombolytic agent that is produced by the kidney. It is used to dissolve blood clots in the urinary tract.
**Option C:** Incorrect because tissue plasminogen activator (tPA) is a different thrombolytic agent that is produced by the brain and is used to dissolve blood clots in the brain.
**Clinical Pearl / High-Yield Fact**
Streptokinase can cause bleeding as a side effect, especially when used in high doses. It is essential to monitor patients closely for signs of bleeding, such as bruising or petechiae, when administering streptokinase.
**Correct Answer:** D.